Skip to main content

Table 1 Demographics of the study participants

From: Utility of diffusion-weighted and contrast-enhanced magnetic resonance imaging in diagnosing and differentiating between high- and low-grade uterine endometrial stromal sarcoma

  T2-hyperintense leiomyoma High-grade ESS Low-grade ESS
n 16 11 9
Age (year)
 Median (range) 43 (30–49) 64 (45–78) 42 (29–55)
Menopausal status
 Premenopausal 16 (100.0) 1 (9.1) 8 (88.9)
 Postmenopausal 0 (0.0) 10 (90.9) 1 (11.1)
FIGO staging
 I N/A 5 (45.5) 8 (88.9)
 II N/A 0 (0.0) 0 (0.0)
 III N/A 4 (36.4) 1 (11.1)
 IV N/A 2 (18.2) 0 (0.0)
Treatment
 Surgery alone 16 (100.0) 3 (27.3) 5 (55.6)
 Surgery with adjuvant treatment N/A 7 (63.6) 4 (44.4)
 CCRT alone N/A 1 (9.1) 0 (0.0)
  1. Data in parentheses are percentages
  2. CCRT Combined chemoradiotherapy